Pharmacotherapy of attention-deficit hyperactivity disorder

Canadian Pharmaceutical Journal

Volumn 129, Issue 5, 1996, Pages

  Garritty, Chantelle M ^a  

^a DCS ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CENTRAL STIMULANT AGENT; CLONIDINE; DESIPRAMINE; FLUOXETINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ATTENTION DEFICIT DISORDER; CHILD; DRUG THERAPY; FEMALE; GROWTH RETARDATION; HEADACHE; HUMAN; HYPERACTIVITY; INSOMNIA; MALE; PREVALENCE; SEX DIFFERENCE; SHORT SURVEY; TIC; VERTIGO;

EID: 19144372122     PISSN: 08286914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. Taylor EA. Childhood hyperactivity Br J Psychiatry 1986;149:562-573. Cited in: Simeon JG, Wiggins DM Pharmacotherapy of Attention-Deficit Hyperactivity Disorder. Can J Psychiatry 1993; 38(6):443-448.
2. Taylor EA. Childhood hyperactivity Br J Psychiatry 1986;149:562-573. Cited in: Simeon JG, Wiggins DM Pharmacotherapy of Attention-Deficit Hyperactivity Disorder. Can J Psychiatry 1993; 38(6):443-448.
3. Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 1991;30,5:762-767.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington D.C. American Psychiatric Association, 1994.
5. Safer DJ, Grager JM. A survey of medication treatment for hyperactive/inattentive students J Am Med Assoc 1988;260(15):2256-2258.
6. Pelham WE, Walker JL, Sturges J, et al. Comparative effects of methlyphenidate on ADD girls and ADD boys. J Am Acad Child Adolesc Psychiatry 1989,28(5):773-776
7. Gadow KD Pediatric psychopharmacotherapy, a review of recent research. J Child Psychol & Psychiatry 1992; 33(1) 153-195.
8. Hart-Santora D, Hart LL. Clonidine in attention deficit hyperactivity disorder. Ann Pharmacotherapy 1992;26:37-38
9. Pelham W, Swanson J, Bender Furman M, Schwindt H. Pemoline effects on children with ADHD: a time-response by dose-response analysis of classroom measures. J Am Acad Child Adolesc Psychiatry, 1995;34(11):1504-1513
10. Dulcan MK. Using psychostimulants to treat behavioral disorders of children and adolescents J Child Adolesc Psychopharmacol 1990;1(1):7-20.
11. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry,94.577-588 Cited in. Simeon JG, Wiggins DM Pharmacotherapy of attention deficit hyperactivity disorder Can J Psychiatry 1993;38(6):443-448.
12. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry,94.577-588 Cited in. Simeon JG, Wiggins DM Pharmacotherapy of attention deficit hyperactivity disorder Can J Psychiatry 1993;38(6):443-448.
13. Safer DJ, Krager, JM The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics 1994,94:462-464
14. Pelham WE, Greenslade DE, Vodde-Hamilton MA, et al. Relative efficacy of long acting CNS stimulants on children with attention deficit hyperactivity disorder, a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine and pemoline Pediatrics 1990;86:226-237.
15. Pleak RR. Adverse effects of chewing methylphenidate. Am J Psychiatry 1995;152(5):811.
16. Rosse RB, Licamele WL Slow-release methylphenidate: problems when children chew tablets (letter). J Clin Psychiatry 1984;45:525
17. Elia J. Drug treatment for hyperactive children: therapeutic guidelines Drugs 1993,46(5).863-871
18. Pliszka S. Tricyclic antidepressants in the treatment of children with ADD. J Am Acad Child Psychiatry 1987;26:127-132.
19. Riddle MA, Nelson JC, Kleinman CS, et al Sudden death in children receiving NorpraminTM:a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 1991;30:104-108.
20. Barrickman L, Perry PJ, Allen AJ, Kuperman S, Arndt S, Herrmann KJ, et al. Buprion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34(5):649-657.
21. Pleak RR, Gormly LJ. Effects of Venlafaxine Treatment for ADHD in a child (letter). Am J Psychiatry 1995,153(7):1099
22. Hunt RD, Arnsten A, Asbell MD. An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34(1):50-54.
23. Alessandri SM, Schramm K. Effects of dextroamphetamine on the cognitive and social play of a preschooler with ADHD. J Am Acad Child Adolesc Psychiatry 1991;30(5):768-772.
24. Connors CK, Wells KC, Erhardt D, March J, Schulte A, Osborne S, et al Multimodal therapies: methodologic issues in research and practice. Child Adolesc Clinics of N Amer 1994;3.361-377.